Fruquintinib Hydrochloride Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 1 mg, 5 mg
Reference Brands: Fruzaqla (USA/EU), Elunate (USA/EU)
Category: Oncology Cancer Care
Fruquintinib is an oral vascular endothelial growth factor receptor (VEGFR) inhibitor used for the treatment of metastatic colorectal cancer. It works by selectively blocking VEGFR-1, VEGFR-2, and VEGFR-3, thereby inhibiting tumor angiogenesis and slowing cancer growth. Fruquintinib hydrochloride is available in Capsules and strengths such as 1 mg, 5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fruquintinib hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Fruquintinib hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fruquintinib hydrochloride is used to treat adults with metastatic colorectal cancer who have been previously treated with chemotherapy and other targeted therapies.
Fruquintinib hydrochloride is made from the active ingredient Fruquintinib, a selective VEGFR inhibitor, combined with hydrochloride to form a stable salt for oral use.
The trade name of Fruquintinib hydrochloride is Fruzaqla and Elunate.
Fruquintinib hydrochloride is developed and manufactured by Hutchmed and licensed to Takeda Pharmaceuticals for global distribution.
The generic name is Fruquintinib hydrochloride.
Brand names include Fruzaqla and Elunate.
Fruquintinib hydrochloride is manufactured in China, Japan, and the United States by Hutchmed and Takeda Pharmaceuticals for international oncology markets.
Related Products
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Nintedanib
Strength:
100 mg, 150 mg
Form: Capsules
Reference Brands: Ofev (USA, EU), Vargatef (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
